Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 842.20
-33.35 (-3.81%)
Oct 23, 2026, 2:35 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 42.72 billion as of October 22, 2026. It is the 14,857th most valuable company in the world and the 874th biggest in India. Its market cap has increased by 15.41% in one year.
Market Cap
42.72B
Enterprise Value
45.51B
Revenue
8.52B
Global Rank
Country Rank
#874 India
PE Ratio
144.87
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 42.72B, an increase of 5,772.79%. That is a compound annual growth rate of 97.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 42.72B | 10.97% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sudeep Pharma | 110.12B |
| Akums Drugs and Pharmaceuticals | 105.46B |
| Strides Pharma Science | 92.75B |
| Aarti Pharmalabs | 75.62B |
| Sun Pharma Advanced Research Company | 57.53B |
| Innova Captab | 56.50B |
| RPG Life Sciences | 45.65B |
| Solara Active Pharma Sciences | 30.83B |